Commercial Success for First Probiotic for Stress Management

13 Dec 2011 --- In France, Urgo markets the formula as ImmunoStim Stress, as part of its new ImmunoStim full range of probiotics, sold through pharmacies. French pharmacists were appealed by the innovation and scientific background behind this product.

Dec 13 2011 --- Institut Rosell-Lallemand’s Probio’Stick (a combination of Lactobacillus Rosell-52 and Bifidobacterium Rosell-175), the first probiotic solution proven to alleviate both physical and psychological symptoms of stress, has recently expanded into new territories with launches in France and Mexico by the company’s local partners Urgo and medix, respectively.

In France, Urgo markets the formula as ImmunoStim Stress, as part of its new ImmunoStim full range of probiotics, sold through pharmacies. French pharmacists were appealed by the innovation and scientific background behind this product.

In Mexico, Probio’Stick is sold under trade mark Senex 3. Medix organized a launch tour early November, gathering several hundreds gastroenterologists and internists.

Isabelle Champié, International Marketing Director for Institut Rosell-Lallemand comments: “We are very proud of the success of our Probio’Stick formula among high profile international partners in the healthcare sector. This success is for us the best recognition of our commitment to the scientific & clinical documentation of our products. This formula is the first probiotic preparation to be backed by two clinical studies showing its efficacy on both physical and psychological symptoms of stress and anxiety.” She added: “If stress-relief and well-being are today identified as promising markets, the number of serious, safe and well-documented products is still limited, especially when it comes to psychological benefits, such as those observed with Probio’Stick applying the type of psychological tests traditionally used for drugs.”

Since Institut Rosell-Lallemand developed Probio’Stick formula in 2005, it has been launched in several key markets around the world: China (with Minsheng pharmaceutical), Canada (distributed by Jamieson Laboratories), Scandinavia (with Baltex) and Portugal (with Prisfar).

A first clinical trial, published in 2008 (Diop et al.) showed the preparation’s efficacy to alleviate gastro-intestinal symptoms linked to stress in chronic stress sufferers, mainly abdominal pain and nausea. In 2010, a new study was published by Messaoudi et al., looking into the probiotics’ effects on psychological symptoms this time, using a range of psychological tests as well as a biomarker for stress and anxiety. This unique study concluded to the probiotic’s beneficial effects on general signs of anxiety and depression and to improve one’s ability to cope with the stress of everyday’s life events. These significant effects are supported by several pre-clinical studies.

Probio’Stick combines a patented micro-encapsulation technology — Probiocap — with a blend of two well-documented Institut Rosell-Lallemand strains: Lactobacillus Rosell-52 and Bifidobacterium Rosell-175. Thanks to this protective micro-encapsulation technology, the probiotic resists gastric acids. Packaged in single-dose sticks of flavored powder that dissolves quickly in the mouth, Probio’Stick can be taken anywhere without water and at any time of the day, even between meals when gastric pH is at its lowest. It is recommended to reduce the gastro intestinal symptoms due to stress.

Diop L., Guillou S., Durand H. : Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: A double-blind, placebo-controlled, randomized trial.  Nutrition Research Volume 28, Issue 1, January 2008. Pages 1-5.

Messaoudi M., Lalonde R., Violle N., Javelot H., Desor D, Nejdi A., Bisson J.-F., Rougeot C., Pichelin M., Cazaubiel M. And Cazaubiel J.-M.: Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and humans. Br J Nutr. 2010 Oct 26:1-9.

Related Articles

Business News

BASF: “considerable” Q2 earnings growth, but Nutrition & Health sales stall

27 Jul 2017 --- BASF Group has announced that its second quarter sales rose by 12 percent to €16.3 billion (US$19.11 billion) compared with the same period in 2016. The group states that this was largely attributable to higher prices and volumes. Amid higher raw material costs, the company raised sales prices by 7 percent; this was mainly driven by higher prices in the Chemicals segment. Sales volumes increased by 3 percent. Currency effects had a positive impact on sales and, like portfolio effects, accounted for a 1 percent increase.

Regulatory News

Cargill’s erythritol dental health claim rejected by EFSA

27 Jul 2017 --- Cargill cannot prove its EU Article 14 claim submission [disease risk reduction claim] that there is a cause-and-effect relationship between sugar-free hard confectionery with at least 90 percent erythritol and the reduction of dental plaque, according to the European Food Safety Authority (EFSA).

Business News

Algatech eyes Brazil market following Anvisa approval for astaxanthin line

27 Jul 2017 --- Algatechnologies has received Brazilian Health Regulatory Agency (Anvisa) approval for its all-natural astaxanthin AstaPure to be used as a food ingredient. This approval makes Algatech the first astaxanthin supplier to start marketing its clean-label astaxanthin under the AstaPure brand in Brazil. 

Nutrition & Health News

Binge drinking among young US adults not in college increased

27 July 2017 --- Binge drinking rates are finally down among US college students aged 18 to 24, after years of increases, but they are up among those in the same age group who are not in college, according to a study in the July issue of the Journal of Studies on Alcohol and Drugs. The same study also found that alcohol-related hospitalizations and overdose deaths have increased generally among 18- to 24-year-olds.

Business News

Food and health startups get chance to impress in Innovation Challenge

27 Jul 2017 --- Innovative ingredient projects, carried out by startups that have brought something completely new and unexpected to the food and health markets, will be rewarded as part of the Startup Innovation Challenge during the next Fi Europe & Ni show from November 28 to 30 this year.

More Articles
URL : http://www.nutritioninsight.com:80/news/Commercial-Success-for-First-Probiotic-for-Stress-Management.html